Mercy Oncology and Hematology - Clayton-Clarkson — Ballwin, Missouri

Mercy Oncology and Hematology - Clayton-Clarkson is a clinical research site located in Ballwin, Missouri, United States 63011.

Crixeo Health Trust Score: 85/100 (GOOD). This profile has not yet been claimed by the site owner.

Mercy Oncology and Hematology - Clayton-Clarkson has participated in 92 clinical trials with 87 currently active.

Therapeutic areas: Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, Acute Lymphoblastic Leukemia.

Sponsors: National Cancer Institute (NCI), NRG Oncology, Alliance for Clinical Trials in Oncology.

Sponsor Feasibility Report

Trust Score: 85/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Mercy Oncology and Hematology - Clayton-Clarkson?

Mercy Oncology and Hematology - Clayton-Clarkson has a Crixeo Trust Score of 85/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Mercy Oncology and Hematology - Clayton-Clarkson conducted?

Mercy Oncology and Hematology - Clayton-Clarkson has 92 clinical trials on record, with 87 currently active. Their work covers Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, Acute Lymphoblastic Leukemia.

Is Mercy Oncology and Hematology - Clayton-Clarkson accredited by Crixeo Health?

Mercy Oncology and Hematology - Clayton-Clarkson has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Mercy Oncology and Hematology - Clayton-Clarkson?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.